Red X iconGreen tick iconYellow tick icon

Contact Details

+64 3 479 4262
Associate Professor
MPharm PhD
Research summary
Drug formulation and delivery, drug delivery to the lung


  • PHCY211: Fundamental Pharmaceutical Sciences
  • PHCY220: Integrated modules A
  • PHCY310: Integrated modules B
  • PHCY430: Elective Projects B
  • PHCY480: Honours Research Project
  • PHCY485: Applied Pharmacotherapy and Patient Care for Honours
  • Inter Professional education


  • Programme Co-ordinator for BPharm(Hons) programme
  • PHCY480: Honours Research Project (Course Co-ordinator)
  • PHCY485: Applied Pharmacotherapy and Patient Care for Honours (Course Co-ordinator)
  • Editorial Board: International Journal of Pharmaceutics (Q1, 13th/169 journals in pharmaceutical science, Citescore: 7.6 (Scopus 2019) (2018-Present)
  • Guest editor, International Journal of Pharmaceutics special issue on ‘The respiratory delivery of high dose powders’ (2018)
  • Scientific Advisory Committee member, Drug Delivery to the Lung Conference (2015- Present)
  • The Aerosol Society (2013 to present)
  • Australasian Pharmaceutical Science Association (APSA) (2006 to present)
  • Otago Medical School Research Society: Treasurer (2019 to present), Executive Committee Member (2018)
  • New Zealand Chapter of the Controlled Release Society (2013 to present): Treasurer (May 2019 to present), Executive Committee Member (Oct 2017 to Apr 2019)
  • Otago Global Health Institute: Profiled Network Member (2016 to present)


The research interests of Associate Professor Das revolve around drug delivery, in particular, respiratory drug delivery of powder formulations for treating chronic lung conditions such as COPD, asthma, tuberculosis, lung cancer and lung infections.

His aim is to achieve a fundamental knowledge base on solid state characterisation processes to understand various pharmaceutical processes such as milling, mixing, spray drying, amorphisation, micronisation, crystallisation, relaxation, dissolution, coating and storage. These knowledge and innovating approaches can be used to develop various conventional and controlled release solid dosage forms such as powders for respiratory delivery as well as tablets and capsules for oral delivery.

Associate Professor Das has extensive research networks with collaborators in New Zealand, Australia, Europe, Asia, the United Kingdom and the USA.
For more visit Das laboratory

PhD projects available

Please contact me if you are interested in conducting PhD research in the following areas:

  • Interactions and influence of lung surfactant on dissolution in the lung
  • Solid surface characteristics that influence powder delivery to the lung


Associate Professor Shyamal Das lectures in Pharmaceutical Science at the School of Pharmacy, University of Otago. He is an internationally recognised formulation expert with over 15 years of experience in dry powder inhaler technology.

Associate Professor Das supervises a large productive research group which focuses on drug delivery to the lung to improve therapy for chronic lung conditions such as asthma, chronic obstructive pulmonary disease, cystic fibrosis and tuberculosis. He is currently contributing to the development of inhalers to treat coronaviruses in collaboration with academia and industries.

Associate Professor Das completed his PhD and research fellowships at Monash Institute of Pharmaceutical Sciences. He was a visiting researcher at the University College London (UK), Imperial College London (UK) and the University of Texas at Austin (USA).

Associate Professor Das is also an award-winning passionate lecturer. He has won multiple awards for best teaching and supervision at the University of Otago.

Additional details

Previous positions

  • Research Fellow, Monash Institute of Pharmaceutical Sciences, Monash University, Australia (2008–2013)
  • Teaching Assistant, Department of Pharmaceutics and Department of Pharmacy Practice, Monash University, Australia (2005–2008)
  • Assistant Professor, Department of Pharmacy, Jahangirnagar University, Bangladesh (2003–2004)
  • Lecturer, Department of Pharmacy, Jahangirnagar University, Bangladesh (2000–2003)

Teaching and research awards

  • Winner of the Otago University Students’ Association’s 2017 Teaching Excellence Award: Premier Lecturer Award 2017 Division of Health Sciences
  • Winner of the Otago University Students’ Association’s Supervisor of the Year Award 2017 Division of Health Sciences
  • Winner of the School of Pharmacy’s Excellence in Teaching Award 2016
  • Winner of the Otago University Students’ Association’s 2016 Teaching Excellence Award (Top Five Teacher)
  • Winner of the Otago School of Pharmacy’s Emerging Researcher Award 2016
  • Finalist (top five) for the Australasian Pharmaceutical Scientists Association’s 2016 Early Career Investigator Award
  • Health Research Council of New Zealand’s Emerging Researcher First Grant 2015

School of Pharmacy administrative roles

  • Chair, BPharm(Hons) Committee (since 2014)
  • Co-Chair, School of Pharmacy Research Committee (since 2020) and Member since February 2017)
  • Member, Research and Postgraduate Committee (since March 2019)
  • Member, School of Pharmacy Undergraduate Programmes Committee
  • Member, School of Pharmacy BPharm/BPharm(Hons) Curriculum Committee (since November 2017)
  • Self-Review Coordinator of BPharm(Hons) Programme (2018)
  • Member, School of Pharmacy Admission Working Party (June 2016 to June 2018)


Hare, C., Hadinoto, K., Das, S., & Smith, R. (2024). Dry powder coating in manufacturing processes. Frontiers in Chemical Engineering, 6, 1420110. doi: 10.3389/fceng.2024.1420110 Journal - Research Other

Fan, C., Eedara, B. B., Sinha, S., Udden, M. K. M., Doyle, C., Banu, S., & Das, S. C. (2024). Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis. International Journal of Pharmaceutics, 654, 123874. doi: 10.1016/j.ijpharm.2024.123984 Journal - Research Article

Khadka, P., Dummer, J., Hill, P. C., & Das, S. C. (2024). The quest to deliver high-dose rifampicin: Can the inhaled approach help? [Review]. Expert Opinion on Drug Delivery, 21(1), 31-44. doi: 10.1080/17425247.2024.2301931 Journal - Research Other

Saha, T., Lyons, N., Yung, D. B. Y., Quiñones‑Mateu, M. E., Pletzer, D., & Das, S. C. (2024). Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections. European Journal of Pharmaceutics & Biopharmaceutics, 195, 114170. doi: 10.1016/j.ejpb.2023.12.010 Journal - Research Article

Das, S. (2023, January). Inhaler delivery for treating COVID-19. Faculty of Pharmacy Seminar, University of Dhaka, Dhaka, Bangladesh. [Department Seminar]. Other Research Output

Back to top